Reuters logo
BRIEF-Novogen ‍enters into deal to license & assign preclinical assets
November 12, 2017 / 11:00 PM / 9 days ago

BRIEF-Novogen ‍enters into deal to license & assign preclinical assets

Nov 13 (Reuters) - Novogen Ltd:

* ‍Entered into agreement to license & assign certain preclinical assets to Heaton-Brown Life Sciences​

* ‍Under terms of deal, co to receive 10 percent of equity in Heaton-Brown Life Sciences Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below